Skip to main content
See every side of every news story
Published loading...Updated

J&J enters agreement to acquire Atraverse Medical

Johnson & Johnson (J&J) recently announced it has entered into a definitive agreement to acquire Atraverse Medical—a company attempting to pioneer next-generation left-heart access and radiofrequency (RF) technologies. Achieving safe and precise access to the left atrium remains “one of the most critical steps” in atrial fibrillation (AF) ablation, as noted in a J&J press release. Atraverse’s Hotwire transseptal access system—already used in nea…
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

Cardiovascular News broke the news on Wednesday, May 6, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal